Published in Infect Immun on October 30, 2006
Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis. J Immunol (2009) 1.22
CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance. PLoS Pathog (2009) 1.06
The p38 MAPK Pathway in Rheumatoid Arthritis: A Sideways Look. Open Rheumatol J (2012) 0.99
Epigenome-wide association study reveals longitudinally stable DNA methylation differences in CD4+ T cells from children with IgE-mediated food allergy. Epigenetics (2014) 0.98
Inhibitory effects of traditional herbal formula pyungwi-san on inflammatory response in vitro and in vivo. Evid Based Complement Alternat Med (2013) 0.89
TGFbeta activates mitogen- and stress-activated protein kinase-1 (MSK1) to attenuate cell death. J Biol Chem (2010) 0.88
Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth. Mol Oncol (2015) 0.85
Norisoboldine inhibits the production of pro-inflammatory cytokines in lipopolysaccharide-stimulated RAW 264.7 cells by down-regulating the activation of MAPKs but not NF-κB. Inflammation (2010) 0.84
The MEK/ERK pathway is the primary conduit for Borrelia burgdorferi-induced inflammation and P53-mediated apoptosis in oligodendrocytes. Apoptosis (2014) 0.84
Anti-inflammatory effects of bangpungtongsung-san, a traditional herbal prescription. Evid Based Complement Alternat Med (2012) 0.84
Adiponectin inhibits neutrophil apoptosis via activation of AMP kinase, PKB and ERK 1/2 MAP kinase. Apoptosis (2013) 0.83
Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways. Exp Mol Pathol (2007) 0.83
Macrophage p38 mitogen-activated protein kinase activity regulates invariant natural killer T-cell responses during Borrelia burgdorferi infection. J Infect Dis (2012) 0.83
Borrelia burgdorferi lipoprotein BmpA activates pro-inflammatory responses in human synovial cells through a protein moiety. Microbes Infect (2008) 0.83
Porcine circovirus type 2 activates PI3K/Akt and p38 MAPK pathways to promote interleukin-10 production in macrophages via Cap interaction of gC1qR. Oncotarget (2016) 0.79
The p38alpha mitogen-activated protein kinase as a central nervous system drug discovery target. BMC Neurosci (2008) 0.79
Piceatannol inhibits MMP-9-dependent invasion of tumor necrosis factor-α-stimulated DU145 cells by suppressing the Akt-mediated nuclear factor-κB pathway. Oncol Lett (2012) 0.79
Bridelia ferruginea Produces Antineuroinflammatory Activity through Inhibition of Nuclear Factor-kappa B and p38 MAPK Signalling. Evid Based Complement Alternat Med (2012) 0.78
Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation. Oncotarget (2016) 0.78
Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling. Drug Des Devel Ther (2015) 0.77
Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(-/-) mice. J Transl Med (2014) 0.76
IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production. Oncotarget (2015) 0.76
Vigilant Keratinocytes Trigger Pathogen-Associated Molecular Pattern Signaling in Response to Streptococcal M1 Protein. Infect Immun (2015) 0.75
Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury. Neural Regen Res (2017) 0.75
The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells. Oncotarget (2017) 0.75
Mice bone marrow Sca-1(+)/CD44(+)mesenchymal stem cells kill avirulent mycobacteria but not Mycobacterium tuberculosis through modulation of cathelicidin expression via p38 MAPK dependent pathway. Infect Immun (2017) 0.75
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (1995) 11.89
The p38 signal transduction pathway: activation and function. Cell Signal (2000) 6.18
Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med (1998) 6.18
Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J (1998) 5.70
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature (1983) 5.20
Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol (1990) 5.08
Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J (2003) 4.22
Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science (1998) 3.68
Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem (1998) 3.21
Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol (2002) 2.98
Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution. Chem Biol (1998) 2.73
The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat Rev Immunol (2006) 2.68
Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J (1998) 2.41
Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol (2005) 2.19
Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun (1993) 2.18
Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem (1998) 2.12
Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct. J Immunol (1991) 2.09
Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J (2002) 1.98
Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. J Immunol (1991) 1.90
Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase. J Biol Chem (1998) 1.87
Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol (1995) 1.86
MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol (2004) 1.85
Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect Immun (2004) 1.72
Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc Natl Acad Sci U S A (2006) 1.58
In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect Immun (1992) 1.55
MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J Immunol (2006) 1.45
p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation. Biochem J (2004) 1.45
ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Signal (2006) 1.41
Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis. Proc Natl Acad Sci U S A (2006) 1.37
Activation of human monocytic cells by Borrelia burgdorferi and Treponema pallidum is facilitated by CD14 and correlates with surface exposure of spirochetal lipoproteins. J Immunol (1999) 1.36
Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol (1997) 1.35
Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-kappa B and inflammatory activation in human endothelial cells. J Immunol (1996) 1.30
Inhibition of NF-kappaB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. J Biol Chem (2000) 1.30
Effects of climate on variability in Lyme disease incidence in the northeastern United States. Am J Epidemiol (2003) 1.25
Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect Immun (1996) 1.22
Adaptation of Borrelia burgdorferi in the tick and the mammalian host. FEMS Microbiol Rev (2003) 1.19
Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1. J Immunol (2006) 1.19
TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation. Blood (2006) 1.16
Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity. Nat Struct Biol (2003) 1.16
MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in interleukin-18-independent mice infected with Borrelia burgdorferi. Infect Immun (2006) 1.16
Toll-like receptor 2 and mitogen- and stress-activated kinase 1 are effectors of Mycobacterium avium-induced cyclooxygenase-2 expression in macrophages. J Biol Chem (2004) 1.04
Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis. J Autoimmun (2001) 1.01
Precipitation and the occurrence of lyme disease in the northeastern United States. Vector Borne Zoonotic Dis (2004) 1.00
Toll-like receptor 2 plays a pivotal role in host defense and inflammatory response to Borrelia burgdorferi. Vector Borne Zoonotic Dis (2002) 0.99
Murine Lyme arthritis development mediated by p38 mitogen-activated protein kinase activity. J Immunol (2002) 0.97
Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells. J Infect Dis (1994) 0.92
Docosahexaenoic acid consumption inhibits deoxynivalenol-induced CREB/ATF1 activation and IL-6 gene transcription in mouse macrophages. J Nutr (2006) 0.90
Control of Borrelia burgdorferi-specific CD4+-T-cell effector function by interleukin-12- and T-cell receptor-induced p38 mitogen-activated protein kinase activity. Infect Immun (2006) 0.90
Dynamic changes in histone H3 phosphoacetylation during early embryonic stem cell differentiation are directly mediated by mitogen- and stress-activated protein kinase 1 via activation of MAPK pathways. J Biol Chem (2006) 0.89
Toll-like receptors in Borrelia burgdorferi-induced inflammation. Clin Microbiol Infect (2006) 0.88
Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release. Infect Immun (1999) 0.87
Low cell cholesterol levels increase NFkappaB activity through a p38 MAPK-dependent mechanism. Cell Signal (2006) 0.86
Nuclear migration of NF-kappa B correlates with TNF-alpha mRNA accumulation. J Inflamm (1995) 0.84
Inhibition of CREB transcriptional activity in human T lymphocytes by oxidative stress. Free Radic Biol Med (2005) 0.80
Lyme disease. Curr Opin Rheumatol (2001) 0.79
The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature (2005) 2.82
Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med (2002) 2.77
Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol (2008) 2.49
Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation. J Exp Med (2002) 1.61
Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15. J Immunol (2006) 1.39
Role of catalase and oxyR in the viable but nonculturable state of Vibrio vulnificus. FEMS Microbiol Ecol (2004) 1.33
A chromosomally encoded virulence factor protects the Lyme disease pathogen against host-adaptive immunity. PLoS Pathog (2009) 1.24
Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis. J Immunol (2009) 1.22
Notch signaling regulates mouse and human Th17 differentiation. J Immunol (2011) 1.21
Adaptation of Borrelia burgdorferi in the tick and the mammalian host. FEMS Microbiol Rev (2003) 1.19
Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agent. Cell Host Microbe (2009) 1.19
CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis of Borrelia burgdorferi. Proc Natl Acad Sci U S A (2012) 1.18
Conformational rearrangement within the soluble domains of the CD4 receptor is ligand-specific. J Biol Chem (2007) 1.17
Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector. Future Microbiol (2013) 1.12
Establishment of a bluetongue virus infection model in mice that are deficient in the alpha/beta interferon receptor. PLoS One (2009) 1.08
Borrelia burgdorferi induces inflammatory mediator production by murine microglia. J Neuroimmunol (2002) 1.04
T-cell signaling pathways inhibited by the tick saliva immunosuppressor, Salp15. FEMS Immunol Med Microbiol (2007) 1.04
Characterization of unique regions of Borrelia burgdorferi surface-located membrane protein 1. Infect Immun (2010) 1.00
Staphylococcus aureus - induced tumor necrosis factor - related apoptosis - inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblasts. BMC Microbiol (2003) 1.00
Substance P augments Borrelia burgdorferi-induced prostaglandin E2 production by murine microglia. J Immunol (2004) 1.00
Synthetic mimics of antimicrobial peptides with immunomodulatory responses. J Am Chem Soc (2012) 1.00
Murine Lyme arthritis development mediated by p38 mitogen-activated protein kinase activity. J Immunol (2002) 0.97
MCJ/DnaJC15, an endogenous mitochondrial repressor of the respiratory chain that controls metabolic alterations. Mol Cell Biol (2013) 0.97
Phosphorylation of Nur77 by the MEK-ERK-RSK cascade induces mitochondrial translocation and apoptosis in T cells. J Immunol (2009) 0.95
c-Jun N-terminal kinase 1 is required for Toll-like receptor 1 gene expression in macrophages. Infect Immun (2007) 0.92
Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virus. Liver Int (2010) 0.91
CD14 targets complement receptor 3 to lipid rafts during phagocytosis of Borrelia burgdorferi. Int J Biol Sci (2013) 0.91
ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe. Parasit Vectors (2014) 0.90
The tick salivary protein, Salp15, inhibits the development of experimental asthma. J Immunol (2007) 0.90
Control of Borrelia burgdorferi-specific CD4+-T-cell effector function by interleukin-12- and T-cell receptor-induced p38 mitogen-activated protein kinase activity. Infect Immun (2006) 0.90
IP3 receptor-mediated Ca2+ release in naive CD4 T cells dictates their cytokine program. J Immunol (2008) 0.89
Expression and localization of five members of the testis-specific serine kinase (Tssk) family in mouse and human sperm and testis. Mol Hum Reprod (2010) 0.88
Identification of synthetic host defense peptide mimics that exert dual antimicrobial and anti-inflammatory activities. Clin Vaccine Immunol (2012) 0.87
Distinct bacterial dissemination and disease outcome in mice subcutaneously infected with Borrelia burgdorferi in the midline of the back and the footpad. FEMS Immunol Med Microbiol (2005) 0.87
Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus. PLoS One (2012) 0.86
The effects of silver nanoparticles on oyster embryos. Mar Environ Res (2009) 0.84
Macrophage p38 mitogen-activated protein kinase activity regulates invariant natural killer T-cell responses during Borrelia burgdorferi infection. J Infect Dis (2012) 0.83
The immunosuppresive tick salivary protein, Salp15. Adv Exp Med Biol (2009) 0.83
Borrelia burgdorferi lipoprotein BmpA activates pro-inflammatory responses in human synovial cells through a protein moiety. Microbes Infect (2008) 0.83
Delivery of the immunosuppressive antigen Salp15 to antigen-presenting cells by Salmonella enterica serovar Typhimurium aroA mutants. Infect Immun (2004) 0.83
Pathway-selective suppression of chemokine receptor signaling in B cells by LPS through downregulation of PLC-β2. Cell Mol Immunol (2010) 0.82
Effects of temperature on detection of plasmid or chromosomally encoded gfp- and lux-labeled Pseudomonas fluorescens in soil. Environ Biosafety Res (2004) 0.80
Fas ligand deficiency impairs host inflammatory response against infection with the spirochete Borrelia burgdorferi. Infect Immun (2006) 0.80
The tick saliva immunosuppressor, Salp15, contributes to Th17-induced pathology during Experimental Autoimmune Encephalomyelitis. Biochem Biophys Res Commun (2010) 0.78
Passage through Ixodes scapularis ticks enhances the virulence of a weakly pathogenic isolate of Borrelia burgdorferi. Infect Immun (2009) 0.77
The Ixodes scapularis salivary protein, salp15, prevents the association of HIV-1 gp120 and CD4. Biochem Biophys Res Commun (2007) 0.77
Binding of full-length HIV-1 gp120 to CD4 induces structural reorientation around the gp120 core. Biophys J (2006) 0.76
TRAIL expression is induced in both osteoblasts containing intracellular Staphylococcus aureus and uninfected osteoblasts in infected cultures. FEMS Microbiol Lett (2007) 0.76
Impact of local traffic exclusion on near-road air quality: findings from the New York City "Summer Streets" campaign. Environ Pollut (2011) 0.75